Angus to Build $10 Million R&D Plant


Angus Chemical Co., a wholly-owned subsidiary of The Dow Chemical Co., has announced plans to build a $10 million research and development manufacturing plant in Sterlington, La. to assist in scale-up and validation of next-generation nitroalkane-based products.

Both Angus and Dow Biocides make biocides used in metalworking fluids and other applications.

Angus expects to break ground in 2008 and begin product validation in 2010. Through the validation process, the company learns how products will work on a larger scale before making the decision to scale-up production.

Located on the Angus manufacturing campus, the new facility will suppport the development of processes and products for a variety of market segments, including metalworking fluids. The plant produces more than 40 specialty products for a variety of industries.

Mark Henning, president and chief executive officer of Angus, said the company has plans for several new products in various market applications. It will validate them using the new research and development manufacturing plant.

This plant will allow us to efficiently test the market validity of new technologies so we can continue providing customers with next-generation products to help them differentiate and grow, Henning said.

Related Topics

Market Topics